Medicine and Dentistry
Patient
100%
Diffuse Large B-Cell Lymphoma
48%
Therapeutic Procedure
44%
Inpatient
28%
Lymphoma
22%
Multiple Myeloma
17%
Cohort Analysis
16%
Diagnosis
14%
Diseases
12%
Acute Myeloid Leukemia
11%
Malignant Neoplasm
11%
Overall Survival
11%
Prognosis
10%
B Cell
10%
Rituximab
9%
Analysis
9%
Gene
9%
Myeloma
9%
Venous Thromboembolism
8%
Follow up
8%
Neoplasm
8%
PET-CT
7%
Hodgkin's Lymphoma
7%
Age
7%
Spontaneous Remission
7%
Chemotherapy
6%
Assessment
6%
Survival
6%
International Prognostic Index
6%
Hazard Ratio
6%
Cells
6%
Progression Free Survival
5%
Non-Hodgkin Lymphoma
5%
Autologous Stem Cell Transplantation
5%
Hospital
5%
Evaluation Study
5%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
5%
Hematological Cancer
5%
Follicular Lymphoma
5%
Biological Marker
5%
Biochemistry, Genetics and Molecular Biology
Gene
6%
MicroRNA
6%
B Cell
5%
Bone
5%
Protein
5%